Consensus Aemetis, Inc.

Equities

AMTX

US00770K2024

Market Closed - Nasdaq 04:00:00 2024-06-07 pm EDT 5-day change 1st Jan Change
3.1 USD -1.74% Intraday chart for Aemetis, Inc. -10.14% -40.84%

Evolution of the average Target Price on Aemetis, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c026e387f221ad7ef81.cpeXhBp2XbSnl0Lq3xCF3AOObWOEY8O5cMkLUux7Me4.St_wtnxHLfLW4QyolV206Ve3HyTyBoXyOppKJ58qfo8tpaLFQxcJjMriEw~c1a73eb9948ab5b024bec9066acfafbb
Truist Adjusts Price Target on Aemetis to $4 From $3.50, Maintains Hold Rating MT
Stifel Trims Price Target on Aemetis to $6.50 From $8, Maintains Buy Rating MT
Stifel Nicolaus Adjusts Aemetis Price Target to $8 From $7.50, Maintains Buy Rating MT
Truist Securities Cuts Price Target on Aemetis to $3.50 From $5, Maintains Hold Rating MT
Stifel Adjusts Aemetis' Price Target to $7.50 From $10, Keeps Buy Rating MT
UBS Adjusts Aemetis Price Target to $9.50 From $10.50, Maintains Buy Rating MT
Stifel Adjusts Aemetis' Price Target to $10.50 From $9, Keeps Buy Rating MT
UBS Upgrades Aemetis to Buy From Neutral, Adjusts Price Target to $10.50 From $2.50 MT
Stifel Adjusts Aemetis' Price Target to $9.50 From $9, Keeps Buy Rating MT
Piper Sandler Adjusts Price Target on Aemetis to $3 From $2, Maintains Underweight Rating MT
Stifel Adjusts Price Target on Aemetis to $10 From $18, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on Aemetis to $2.50 From $5, Maintains Hold Rating MT
UBS Adjusts Price Target on Aemetis to $2.50 From $4.25, Maintains Neutral Rating MT
Tudor Adjusts Price Target on Aemetis to $4 From $8, Maintains Hold Rating MT
Piper Sandler Starts Aemetis at Underweight With $3 Price Target MT
Stifel Nicolaus Adjusts Aemetis Price Target to $18 From $21, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on Aemetis to $5 From $9, Maintains Hold Rating MT
UBS Initiates Coverage on Aemetis With Neutral Rating, $4.25 Price Target MT
Tudor Pickering Lowers Aemetis Price Target to $8 From $9, Maintains Hold Rating MT
Tudor Pickering Raises Aemetis' Price Target to $9 From $7, Maintains Hold Rating MT
Truist Securities Downgrades Aemetis to Hold From Buy; Price Target is $12 MT
Credit Suisse Lowers Aemetis' Price Target to $27 from $35, Lowers Estimates to Reflect Delays in Project Execution; Keeps Outperform Rating MT
Tudor Pickering Holt Lowers Aemetis' Price Target to $9 From $13, Maintains Hold Rating MT
Credit Suisse Lifts Aemetis' PT to $35 from $31, Notes $1 Billion Sales Agreement with Delta Airlines, Keeps Outperform Rating MT
Tudor Initiates Aemetis at Hold With $20 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
3.1 USD
Average target price
11.58 USD
Spread / Average Target
+273.66%
High Price Target
28 USD
Spread / Highest target
+803.23%
Low Price Target
3 USD
Spread / Lowest Target
-3.23%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Aemetis, Inc.

Truist Securities
Stifel Nicolaus
UBS
Piper Sandler
Tudor Pickering Holt & Co.
Credit Suisse
Evercore ISI
HC Wainwright
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock Market
  2. Equities
  3. AMTX Stock
  4. Consensus Aemetis, Inc.